June 2018

Important New Products

• Avelumab (rch) (Bavencio) is a fully human IgG1 monoclonal antibody directed against ...(more)
• Cladribine (Mavenclad) is a nucleoside analogue of deoxyadenosine. The mechanism by ...(more)
• Dulaglutide (rch) (Trulicity) is an engineered long-acting GLP-1 receptor agonist, with ...(more)
• Fluticasone furoate/umeclidinium (bromide)/vilanterol (trifenatate) (Trelegy Ellipta) ...(more)
• Pegaspargase (Oncaspar) is a modified (pegylated) version of the enzyme asparaginase, ...(more)

Active Ingredient Naming Changes

In this release, MIMS Australia will be including the following INNs (International Non-proprietary Names) as well as Australian Approved Names (AANs) as part of our push to support the Therapeutic Goods Administration (TGA) active ingredient name changes project.  

MIMS will begin referring to these ingredients by their new names, however, users may continue to search by the old AANs if preferred. ...(more)